Tolerability and outcome of sunitinib by giving 4/2 schedule versus 2/1 schedule in metastatic renal cell carcinoma patients: a prospective randomized multi-centric Egyptian study - Abdelaziz, Lobna A.; Taha, Heba F.; M. Ali, Magid; Abdelgawad, Marwa I.; Elwan, Amira (Contemporary Oncology/Współczesna Onkologia, 2020)